WX2-43

WX2-43 is a potent and selective PRMT5 inhibitor that disrupts KLF4-mediated transcription, leading to suppressed cancer cell survival. It demonstrates efficacy in both cellular assays and in vivo models, effectively inhibiting breast tumor progression in preclinical research.